CYCCP
Price
$5.33
Change
+$0.05 (+0.95%)
Updated
Jul 2, 04:02 PM (EDT)
Capitalization
N/A
VALN
Price
$5.82
Change
+$0.10 (+1.75%)
Updated
Jul 2, 03:16 PM (EDT)
Capitalization
468.64M
41 days until earnings call
Interact to see
Advertisement

CYCCP vs VALN

Header iconCYCCP vs VALN Comparison
Open Charts CYCCP vs VALNBanner chart's image
Cyclacel Pharmaceuticals
Price$5.33
Change+$0.05 (+0.95%)
Volume$300
CapitalizationN/A
Valneva SE
Price$5.82
Change+$0.10 (+1.75%)
Volume$100
Capitalization468.64M
CYCCP vs VALN Comparison Chart in %
Loading...
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CYCCP vs. VALN commentary
Jul 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CYCCP is a Hold and VALN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 03, 2025
Stock price -- (CYCCP: $5.28 vs. VALN: $5.72)
Brand notoriety: CYCCP and VALN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CYCCP: 241% vs. VALN: 35%
Market capitalization -- CYCCP: $0 vs. VALN: $478.71M
CYCCP [@Biotechnology] is valued at $0. VALN’s [@Biotechnology] market capitalization is $478.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $306.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CYCCP’s FA Score shows that 1 FA rating(s) are green whileVALN’s FA Score has 1 green FA rating(s).

  • CYCCP’s FA Score: 1 green, 4 red.
  • VALN’s FA Score: 1 green, 4 red.
According to our system of comparison, CYCCP is a better buy in the long-term than VALN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CYCCP’s TA Score shows that 3 TA indicator(s) are bullish while VALN’s TA Score has 3 bullish TA indicator(s).

  • CYCCP’s TA Score: 3 bullish, 5 bearish.
  • VALN’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, VALN is a better buy in the short-term than CYCCP.

Price Growth

CYCCP (@Biotechnology) experienced а -3.12% price change this week, while VALN (@Biotechnology) price change was +2.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +33.64%, and the average quarterly price growth was +2.14%.

Reported Earning Dates

VALN is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VALN YTD gains are higher at: 30.833 vs. CYCCP (-25.136). CYCCP has higher annual earnings (EBITDA): -12.68M vs. VALN (-55.24M). VALN has more cash in the bank: 153M vs. CYCCP (3.45M). CYCCP has less debt than VALN: CYCCP (9K) vs VALN (211M). VALN has higher revenues than CYCCP: VALN (186M) vs CYCCP (14K).
CYCCPVALNCYCCP / VALN
CapitalizationN/A469M-
EBITDA-12.68M-55.24M23%
Gain YTD-25.13630.833-82%
P/E RatioN/AN/A-
Revenue14K186M0%
Total Cash3.45M153M2%
Total Debt9K211M0%
FUNDAMENTALS RATINGS
CYCCP: Fundamental Ratings
CYCCP
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
96
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
47
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CYCCPVALN
RSI
ODDS (%)
Bearish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CYCCP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VALN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CGREX9.12N/A
N/A
Invesco Global Real Estate C
RYHRX39.64N/A
N/A
Rydex Real Estate H
NSNAX47.97N/A
N/A
Neuberger Berman Small Cap Growth A
ANODX23.59N/A
N/A
American Century Small Cap Growth R6
CADRX23.00N/A
N/A
Columbia Large Cap Growth Opp Inst2

CYCCP and

Correlation & Price change

A.I.dvisor tells us that CYCCP and SRPT have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYCCP and SRPT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYCCP
1D Price
Change %
CYCCP100%
-3.83%
SRPT - CYCCP
23%
Poorly correlated
+3.57%
LYEL - CYCCP
22%
Poorly correlated
+6.62%
GMAB - CYCCP
22%
Poorly correlated
+0.39%
VALN - CYCCP
22%
Poorly correlated
+0.88%
AURA - CYCCP
21%
Poorly correlated
N/A
More

VALN and

Correlation & Price change

A.I.dvisor indicates that over the last year, VALN has been loosely correlated with INRLF. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VALN jumps, then INRLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VALN
1D Price
Change %
VALN100%
+0.88%
INRLF - VALN
42%
Loosely correlated
N/A
BMRN - VALN
35%
Loosely correlated
+2.22%
PTCT - VALN
32%
Poorly correlated
-0.51%
IPHA - VALN
32%
Poorly correlated
+1.65%
IMTX - VALN
31%
Poorly correlated
+2.97%
More